Complication of Surgical Procedure
Conditions
Keywords
Wei JET
Brief summary
Testing the efficacy and safety of the WEI Nasal Jet.
Detailed description
This is only initial thought and suggestions from the inventor Dr. Huafeng Wei. Principal investigator from each medical center interested in testing this new device should design their own clinical trials based on patient population and their own ideas for clinical trials. Just remind you that patient safety is number one and try all efforts to minimize patient risks during your clinical study.
Interventions
DEVICEExperimental group and control groupl
JET
Sponsors
University of Pennsylvania
Zeyong Yang
Study design
Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
22 Years to 58 Years
Healthy volunteers
Yes
Inclusion criteria
* Patients receiving various types of surgeries under sedation, especially for procedures of colonoscopy, upper gastrointestinal endoscopy, endoscopic retrograde cholangiopancreatography (ERCP) cystoscopy and other brief surgeries you are interested in the study.
Exclusion criteria
* Patients with coagulopathy and tendency of nose bleeding. * Patients with any diagnosed cardiac diseases (e.g. cardiac failure, angina, MI, cardiac arrhythmia. etc.) * Patients with any diagnosed pulmonary disease (e.g. asthma, COPD, pulmonary embolism, pulmonary edema etc.) * Pregnant patients * Patients with liver failure * Patients with kidney failure
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| lowest SaO2 in Wei JET group | 2 second | Compare with Control group,there was no significant difference in lowest SaO2 in Wei JET group. |
Outcome results
None listed